Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Hideo Tahara"'
Autor:
Naoki Matsumura, Kazutoshi Fujita, Mitsuhisa Nishimoto, Yutaka Yamamoto, Ken Kuwahara, Yasuharu Nagai, Takafumi Minami, Yuji Hatanaka, Masahiro Nozawa, Yasuhiro Morimoto, Hideo Tahara, Shigeya Uejima, Atsunobu Esa, Akihide Hirayama, Kazuhiro Yoshimura, Hirotsugu Uemura
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
This study aimed to compare the effects of abiraterone acetate plus prednisone (AAP) with androgen deprivation therapy (ADT) with those of combined androgen blockade (CAB) therapy in patients with high-risk metastatic hormone-sensitive prostate cance
Externí odkaz:
https://doaj.org/article/f92ba2e2dfeb49a58807315bbf859ffa
Autor:
SHOGO ADOMI, KAZUTOSHI FUJITA, HIROYUKI KITA, KEN KUWAHARA, YASUNORI AKASHI, MITSUHISA NISHIMOTO, NAOKI MATSUMURA, KOICHI SUGIMOTO, TAKAFUMI MINAMI, MASAHIRO NOZAWA, KAZUHIRO YOSHIMURA, HIDEO TAHARA, AKIHIDE HIRAYAMA, TSUKASA NISHIOKA, ATSUNOBU ESA, HIROTSUGU UEMURA
Publikováno v:
Cancer Diagnosis & Prognosis; Jul/Aug2023, Vol. 3 Issue 4, p484-490, 7p
Autor:
Naoki Matsumura, Kazutoshi Fujita, Mitsuhisa Nishimoto, Takafumi Minami, Hideo Tahara, Kazuhiro Yoshimura, Hirotsugu Uemura
Publikováno v:
World Journal of Urology.
The therapeutic landscape for metastatic hormone-sensitive prostate cancer (mHSPC) has changed dramatically. Here, we provide the current status and future prospective of the management of mHSPC.We reviewed recent literature of landmark studies on th
Publikováno v:
The Japanese Journal of Urology. 112:105-108
The patient was a 65-year-old male who was referred with right renal mass (8 × 6.7 cm) and swelling of para-aortic lymph nodes in CT in April, 20XX. Additional examinations revealed inferior vena cava invasion, multiple lung metastases and left ilia
Publikováno v:
American Journal of Case Reports. 5/7/2018, Vol. 19, pCS47-CS52. 6p.
Autor:
Naoki Matsumura, Kazuhiro Nose, Sachiko Hongo, Hideo Tahara, Yasunori Mori, Takafumi Minami, Mamoru Hashimoto, Nobutaka Shimizu, Kazuhiro Yoshimura, Koichi Sugimoto, Takayuki Ohzeki, Masahiro Nozawa, Hirotsugu Uemura
Publikováno v:
Urologia Internationalis. 101:74-79
Introduction: We investigated whether the change in the neutrophil lymphocyte ratio (NLR) from the first to the last repeat prostate biopsy (ΔNLR) could be the diagnostic tool or not for prostate cancer (PCa) detection. Materials and Methods: We ret
Autor:
Hideo Tahara, Kazuhiro Yoshimura, Hirotsugu Uemura, Nobutaka Shimizu, Takafumi Minami, Mamoru Hashimoto, Masahiro Nozawa, Akihide Hirayama, Koichi Sugimoto, Sachiko Hongoh
Publikováno v:
LUTS: Lower Urinary Tract Symptoms. 9:157-160
Objectives To assess the efficacy of dutasteride add-on therapy for patients with benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS) with small prostates who have been treated with α-blocker therapy for >3 months. Methods A t
Autor:
Eri Banno, Yasuharu Nagai, Aki Nishino, Norihumi Kanno, Muneo Yasuda, Hideo Tahara, Shigeo Kino
Publikováno v:
The Japanese Journal of Urology. 106:206-210
A 42-year-old man was referred to our hospital for macrohematuria. Computer tomography and magnetic resonance imaging revealed right hydronephrosis and a retroperitoneal mass, located next to right side of the bladder. Cystoscopy showed a protruded l
Autor:
Hirotsugu Uemura, Nobutaka Shimizu, Tsukasa Nishioka, Hiroshi Kajikawa, Masaaki Imanishi, Atsunobu Esa, Kazuhiro Nose, Koichi Sugimoto, Hideo Tahara
Publikováno v:
Journal of Cancer
Background: This study was undertaken to investigate the growth rate and clinical outcome of patients with a small renal mass (SRM) after delayed surgery versus immediate surgery. Methods: We reviewed the clinical records of 328 patients with SRM ≦
Autor:
Atsunobu Esa, Nobutaka Shimizu, Yuji Hatanaka, Hideo Tahara, Koichi Sugimoto, Hiroyuki Koike, Yoshitaka Saitou, Marco A. De Velasco, Masaaki Imanishi, Kiyoshi Hashimoto, Hirotsugu Uemura
Publikováno v:
Current Urology. 5:41-45
Background: Bacillus Calmette-Guerin (BCG) instillation has been considered to be the most effective method of treatment for non-muscle invasive bladder cancer. The objective of the